153 related articles for article (PubMed ID: 21381283)
1. [Immune reconstitution and regulation following autologous hematopoietic transplantation using palifermin].
Pérez-Roca L; Sánchez-Ortega I; Duarte RF
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():15-7. PubMed ID: 21381283
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
Seggewiss R; Einsele H
Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184
[TBL] [Abstract][Full Text] [Related]
3. The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant.
Nasilowska-Adamska B; Rzepecki P; Manko J; Czyz A; Markiewicz M; Federowicz I; Tomaszewska A; Piatkowska-Jakubas B; Wrzesien-Kus A; Bieniaszewska M; Duda D; Szydlo R; Halaburda K; Szczepinski A; Lange A; Hellman A; Robak T; Skotnicki A; Jedrzejczak WW; Walewski J; Holowiecki J; Komarnicki M; Dmoszynska A; Warzocha K; Marianska B
Bone Marrow Transplant; 2007 Nov; 40(10):983-8. PubMed ID: 17846600
[TBL] [Abstract][Full Text] [Related]
4. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
[TBL] [Abstract][Full Text] [Related]
5. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
Langner S; Staber P; Schub N; Gramatzki M; Grothe W; Behre G; Rabitsch W; Urban C; Linkesch W; Neumeister P
Bone Marrow Transplant; 2008 Aug; 42(4):275-9. PubMed ID: 18500368
[TBL] [Abstract][Full Text] [Related]
6. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
Radtke ML; Kolesar JM
J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
[TBL] [Abstract][Full Text] [Related]
7. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
[TBL] [Abstract][Full Text] [Related]
8. Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience.
Rzepecki P; Sarosiek T; Barzal J; Oborska S; Nurzynski P; Wasko A; Szczylik C
J BUON; 2007; 12(4):477-82. PubMed ID: 18067205
[TBL] [Abstract][Full Text] [Related]
9. Palifermin for patients with haematological malignancies: shifting nursing practice from symptom relief to prevention of oral mucositis.
Fliedner M; Baguet B; Blankart J; Davies M; Henriques E; Leather A; Mazur E; Mihály K; Peeters L; Radványiné A; Sedlackova B
Eur J Oncol Nurs; 2007; 11 Suppl 1():S19-26. PubMed ID: 17540295
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
11. Acanthosis nigricans in a patient treated with palifermin.
Lee M; Grassi M
Cutis; 2010 Sep; 86(3):136-7. PubMed ID: 21049730
[TBL] [Abstract][Full Text] [Related]
12. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
McDonnell AM; Lenz KL
Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
[TBL] [Abstract][Full Text] [Related]
13. [Palifermin in the preventive treatment of oral mucositis in autograft patients: data on efficacy and tolerance following marketing approval].
Onteniente S; Coullet V; Chemelle M; Lafont I; Pernot C; Guignard MH
Therapie; 2008; 63(1):37-42. PubMed ID: 18387274
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation.
Schlenke P; Sheikhzadeh S; Weber K; Wagner T; Kirchner H
Bone Marrow Transplant; 2001 Aug; 28(3):251-7. PubMed ID: 11535992
[TBL] [Abstract][Full Text] [Related]
16. [Regeneration of the immune system after bone marrow transplantation].
Uher F; Puskás E; Torbágyi E; Barta A; Kormos L; Pálóczi K
Orv Hetil; 2001 Jan; 142(2):59-65. PubMed ID: 11209506
[TBL] [Abstract][Full Text] [Related]
17. Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis.
Czyzewski K; Debski R; Krenska A; Wysocki M; Styczynski J
Anticancer Res; 2014 Dec; 34(12):7379-82. PubMed ID: 25503176
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte growth factor and stem cell factor to improve thymopoiesis after autologous CD34+ cell transplantation in rhesus macaques.
Wils EJ; Aerts-Kaya FS; Rombouts EJ; van Mourik I; Rijken-Schelen A; Visser TP; Braakman E; Wagemaker G; Cornelissen JJ
Biol Blood Marrow Transplant; 2012 Jan; 18(1):55-65. PubMed ID: 21963880
[TBL] [Abstract][Full Text] [Related]
19. Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children.
Eyrich M; Wollny G; Tzaribaschev N; Dietz K; Brügger D; Bader P; Lang P; Schilbach K; Winkler B; Niethammer D; Schlegel PG
Biol Blood Marrow Transplant; 2005 Mar; 11(3):194-205. PubMed ID: 15744238
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
